@article{1200e3c73efb45ffbce712b21973062a,
title = "Antimetastatic defense by CD8+ T cells",
abstract = "Metastasis is an intricate process whereby tumor cells migrate from the primary tumor, survive in the circulation, seed distal organs, and proliferate to create metastatic foci. CD8+ T cells can detect and eliminate tumor cells. Research on CD8+ T cell–dependent antitumor immunity has classically focused on its role in the primary tumor. There is increasing evidence, however, that CD8+ T cells have unique antimetastatic functions in various steps of the metastatic cascade. Here, we review the mechanisms whereby CD8+ T cells control metastatic lesions. We discuss their role in each step of metastasis, metastatic dormancy, and metastatic clonal evolution as well as the consequent clinical repercussions.",
keywords = "CD8 T cells, immunoediting, metastasis, metastatic dormancy",
author = "{Tall{\'o}n de Lara}, Paulino and H{\'e}ctor Casta{\~n}{\'o}n and Michelle Sterpi and {van den Broek}, Maries",
note = "Funding Information: We thank the Mount Sinai West and Mount Sinai Morningside Internal Medicine program{\textquoteright}s leadership for their strong support. This work was supported by the Swiss National Science Foundation [SNSF; 310030_175565 (M.v.d.B.)], the Swiss Cancer League [Oncosuisse; KLS-4098-02-2017 (M.v.d.B.)], the University of Zurich Forschungskredit (P.T.d.L., H.C.), the University Research Priority Program (URPP) Translational Cancer Research (M.v.d.B.), the Hartmann-M{\"u}ller Foundation Zurich (M.v.d.B.), and the Monique-Dornonville-de-la-Cour Foundation Zurich (M.v.d.B.). We apologize to our colleagues for not citing their excellent work due to space limitations. Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",
year = "2022",
month = feb,
doi = "10.1016/j.trecan.2021.10.006",
language = "English",
volume = "8",
pages = "145--157",
journal = "Trends in Cancer",
issn = "2405-8033",
publisher = "Cell Press",
number = "2",
}